Abbott LaboratoriesABTNYSE
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank64
3Y CAGR+61.7%
5Y CAGR-7.7%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+61.7%/yr
vs -41.7%/yr prior
5Y CAGR
-7.7%/yr
Recent acceleration
Acceleration
+103.4pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 5.67% |
| 2024 | 4.59% |
| 2023 | -8.12% |
| 2022 | 1.34% |
| 2021 | 24.47% |
| 2020 | 8.48% |
| 2019 | 4.34% |
| 2018 | 11.64% |
| 2017 | 31.35% |
| 2016 | 2.20% |